ARVN vs. KYMR
Compare and contrast key facts about Arvinas, Inc. (ARVN) and Kymera Therapeutics, Inc. (KYMR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARVN or KYMR.
Correlation
The correlation between ARVN and KYMR is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ARVN vs. KYMR - Performance Comparison
Key characteristics
ARVN:
-0.94
KYMR:
-0.30
ARVN:
-1.50
KYMR:
0.01
ARVN:
0.77
KYMR:
1.00
ARVN:
-0.84
KYMR:
-0.26
ARVN:
-1.77
KYMR:
-0.81
ARVN:
44.66%
KYMR:
24.15%
ARVN:
84.70%
KYMR:
67.20%
ARVN:
-94.26%
KYMR:
-87.51%
ARVN:
-93.69%
KYMR:
-64.97%
Fundamentals
ARVN:
$556.92M
KYMR:
$2.19B
ARVN:
-$0.66
KYMR:
-$2.98
ARVN:
1.30
KYMR:
46.45
ARVN:
0.85
KYMR:
2.62
ARVN:
$426.90M
KYMR:
$36.79M
ARVN:
$423.60M
KYMR:
$30.91M
ARVN:
-$91.00M
KYMR:
-$169.25M
Returns By Period
In the year-to-date period, ARVN achieves a -64.48% return, which is significantly lower than KYMR's -23.51% return.
ARVN
-64.48%
10.02%
-75.46%
-78.96%
-33.69%
N/A
KYMR
-23.51%
46.18%
-38.29%
-20.08%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARVN vs. KYMR — Risk-Adjusted Performance Rank
ARVN
KYMR
ARVN vs. KYMR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arvinas, Inc. (ARVN) and Kymera Therapeutics, Inc. (KYMR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARVN vs. KYMR - Dividend Comparison
Neither ARVN nor KYMR has paid dividends to shareholders.
Drawdowns
ARVN vs. KYMR - Drawdown Comparison
The maximum ARVN drawdown since its inception was -94.26%, which is greater than KYMR's maximum drawdown of -87.51%. Use the drawdown chart below to compare losses from any high point for ARVN and KYMR. For additional features, visit the drawdowns tool.
Volatility
ARVN vs. KYMR - Volatility Comparison
Arvinas, Inc. (ARVN) has a higher volatility of 36.48% compared to Kymera Therapeutics, Inc. (KYMR) at 28.00%. This indicates that ARVN's price experiences larger fluctuations and is considered to be riskier than KYMR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ARVN vs. KYMR - Financials Comparison
This section allows you to compare key financial metrics between Arvinas, Inc. and Kymera Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities